Summary: GLP-1 receptor agonists and other anti-obesity medications (AOMs) are valuable tools in obesity treatment, but they are not standalone solutions. Their effectiveness depends on integration into comprehensive care; achieving this requires policy reforms, improved access to interdisciplinary care teams, and efforts to reduce weight bias and stigma.  To advance these goals, the Obesity Medicine Association, […]

Summary: A life science company engaged Atlas Clarity to develop a health equity presentation for its staff that provided guidance on who is currently engaged in health equity now, as well as how community health centers can help in aid research to improve health equity for screening, timely diagnosis, and treatment for lung cancer patients. […]

Summary: The Clubhouse model of psychosocial rehabilitation was developed in 1948 in New York City by Fountain House, a nonprofit mental health organization, to provide people with serious mental illness (SMI) with opportunities for friendship, employment, housing, education, and social skills. There are now 370 clubhouses worldwide and 16 in California, but most are standalone […]

Summary: A life science company sought to better understand patient experience with timely diagnosis and treatment of two rare diseases, neuromyelitis optica spectrum disorders (NMOSD) and generalized myasthenia gravis (gMG), particularly among underserved communities. They contracted Atlas Clarity to conduct a mixed methods study examining the time to diagnosis for both NMOSD and MG and […]

Summary:  Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that causes the body to attack its own organs and tissue. Due to its uncommon nature, it is often hard to diagnose, particularly in disadvantaged populations. While not typically fatal, it can be deadly when left undiscovered and untreated. Individuals who face social determinants of […]